Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Recruiting 2Completed 2

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 2Oligomenorrhea 1Insulin Resistance 1Infertility 1Hyperandrogenism 1Hirsutism 1Diabetes Mellitus, Type 1 1

Interventions

Cyclophosphamide 1495Cisplatin 1431Paclitaxel 1339Radiotherapy 1308Carboplatin 1264Gemcitabine 1225Docetaxel 1134Bevacizumab 1068Fluorouracil 906Doxorubicin 799Dexamethasone 753Rituximab 744Capecitabine 735Oxaliplatin 709pembrolizumab 693Etoposide 674Irinotecan 639Filgrastim 624Nivolumab 585Cytarabine 585Leucovorin 582Vincristine 512Cetuximab 478Prednisone 477Bortezomib 472Trastuzumab 469Erlotinib Hydrochloride 467Surveys and Questionnaires 460Methotrexate 443Lenalidomide 434

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Body Mass Index × Clear all
NCT04979377 2025-03-17

Prevalence of Hyperandrogenism in Type 1 Diabetes

Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal

Completed
150 enrolled

Diabetes Mellitus, Type 1, Hirsutism, Insulin Resistance, Oligomenorrhea, Polycystic Ovary Syndrome, Hyperandrogenism

NCT01909141 2015-10-20

Ovulation Induction in Women With Clomiphene Citrate Resistant PCOS

Cairo University

Phase EARLY_PHASE1 Completed
100 enrolled 23 charts

Infertility, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡